The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany

類似資料

• The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany
  著者:: Dintsios, C. M., 等
  出版事項: (2020)
• Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept
  著者:: Wettstein, Dominik J., 等
  出版事項: (2021)
• Predictors of negotiated prices for new drugs in Germany
  著者:: Gandjour, Afschin, 等
  出版事項: (2020)
• The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
  著者:: Wettstein, Dominik J., 等
  出版事項: (2020)
• Health technology assessment and reimbursement of pharmaceuticals in Italy
  著者:: F. V. Gorkavenko, 等
  出版事項: (2019-07-01)